Archives

by in
Entry Author Date Location
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
RidePal and the Private Bus Wars: Q&A with Founder Nathalie Criou 12/18/13 San Francisco
Gates Foundation Gets UCSF Chief Desmond-Hellmann as New CEO 12/17/13 Seattle
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Building Biotechs to Last: The Photos 12/12/13 San Francisco
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
David Botstein, 71, on Joining Google’s Anti-Aging Play, Calico 11/22/13 San Francisco
Look Who’s Hiring in Biotech: Companies That Are Built to Last 11/21/13 San Francisco
Genentech CMO Hal Barron Joins ‘Building Biotechs to Last’ Dec. 9 11/14/13 San Francisco
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold 11/06/13 Boston
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
21 Red Flags to Watch for in a Biotech Company 10/21/13 National
PSivida, Alimera Shares Fall as FDA Rejects Eye Drug for Third Time 10/18/13 Boston
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
The $100M Club: Where the Major League Life Sciences Companies Are 10/14/13 National
NJ’s Pain is NY’s Gain as Roche Christens Manhattan Collaboration Hub 10/01/13 New York
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Page 2 of 16 « previous page · next page »